Trexquant Investment’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,448
| Closed | -$305K | – | 1892 |
|
|
2023
Q3 | $305K | Buy |
+16,448
| New | +$186K | 0.01% | 1216 |
|
|
2023
Q2 | – | Sell |
-109,078
| Closed | -$1.46M | – | 1907 |
|
|
2023
Q1 | $1.46M | Buy |
109,078
+11,077
| +11% | +$192K | 0.04% | 575 |
|
|
2022
Q4 | $1.21M | Sell |
98,001
-1,851
| -2% | -$26.2K | 0.03% | 583 |
|
|
2022
Q3 | $1.39M | Buy |
99,852
+39,731
| +66% | +$640K | 0.05% | 439 |
|
|
2022
Q2 | $830K | Buy |
+60,121
| New | +$963K | 0.04% | 600 |
|
|
2021
Q4 | – | Sell |
-34,839
| Closed | -$517K | – | 1727 |
|
|
2021
Q3 | $517K | Buy |
+34,839
| New | +$557K | 0.04% | 525 |
|
|
2021
Q2 | – | Sell |
-27,004
| Closed | -$623K | – | 1606 |
|
|
2021
Q1 | $623K | Buy |
+27,004
| New | +$753K | 0.06% | 430 |
|
|
2020
Q4 | – | Sell |
-17,387
| Closed | -$721K | – | 1607 |
|
|
2020
Q3 | $721K | Buy |
+17,387
| New | +$799K | 0.05% | 534 |
|
|
2020
Q2 | – | Sell |
-10,640
| Closed | -$670K | – | 1564 |
|
|
2020
Q1 | $670K | Buy |
+10,640
| New | +$956K | 0.05% | 553 |
|
|
2019
Q4 | – | Sell |
-9,227
| Closed | -$612K | – | 1324 |
|
|
2019
Q3 | $612K | Sell |
9,227
-7,349
| -44% | -$493K | 0.05% | 398 |
|
|
2019
Q2 | $1.32M | Sell |
16,576
-8,933
| -35% | -$800K | 0.12% | 248 |
|
|
2019
Q1 | $2.85M | Buy |
25,509
+13,450
| +112% | +$1.47M | 0.2% | 144 |
|
|
2018
Q4 | $1.22M | Buy |
+12,059
| New | +$1.25M | 0.08% | 383 |
|
|
2018
Q2 | – | Sell |
-37,238
| Closed | -$2.29M | – | 1310 |
|
|
2018
Q1 | $2.29M | Buy |
+37,238
| New | +$2.24M | 0.16% | 203 |
|
|
2016
Q4 | – | Sell |
-6,300
| Closed | -$1.04M | – | 1181 |
|
|
2016
Q3 | $1.04M | Buy |
+6,300
| New | +$993K | 0.23% | 127 |
|
|
2016
Q2 | – | Sell |
-8,729
| Closed | -$1.12M | – | 1166 |
|
|
2016
Q1 | $1.12M | Buy |
+8,729
| New | +$1.03M | 0.13% | 261 |
|
|
2015
Q4 | – | Sell |
-12,900
| Closed | -$2.14M | – | 1330 |
|
|
2015
Q3 | $2.14M | Buy |
12,900
+7,600
| +143% | +$1.67M | 0.18% | 137 |
|
|
2015
Q2 | $1.28M | Buy |
+5,300
| New | +$1.41M | 0.14% | 247 |
|
|
2015
Q1 | – | Sell |
-8,800
| Closed | -$1.37M | – | 1242 |
|
|
2014
Q4 | $1.37M | Buy |
+8,800
| New | +$1.63M | 0.24% | 65 |
|
Trexquant Investment's ICPT Position: Q4 2023 in Review
Trexquant Investment sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 16,448 shares — an estimated $305K sold.
Trexquant Investment first reported a position in ICPT in Q4 2014 and held it in 19 quarters. The position peaked at $2.85M in Q1 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Trexquant Investment reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Trexquant Investment sold 16,448 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $305K.
- Trexquant Investment first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 19 quarters.
- Trexquant Investment's Intercept Pharmaceuticals, Inc. position peaked at $2.85M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.